Launch of the Euro-BioImaging Industry Board website


May 9, 2019
EBIB

The ability to do research depends on the availability of suitable products. It is therefore essential that researchers and imaging facility staff have a clear communication line to a wide range of companies in the field to ensure that the companies understand the trends in research thereby making available suitable products. The Euro-BioImaging Industry Board (EBIB) members consist of a range of companies in the field of imaging, joined together by their recognition of the importance of working closely with the community to ensure that they develop products that are fit for purpose. By working as a single, professional entity and supported by the EBIB Coordinator, EBIB proactively drives the interaction between the imaging industry, European researchers and the imaging facilities linked to the pan-European research infrastructure, Euro-BioImaging.

To keep update with EBIB’s progress and opportunities, please visit its specialised website: eurobioimaging-industryboard.com


More news from Euro-BioImaging

CanSERV logo

September 13, 2024

Call for Independent Scientific Reviewers for canSERV

We are delighted to invite you to become a member of canSERV’s Independent Review Board (IRB) and help streamline European cancer research. The canSERV…

Special Edition Virtual Pub: Innovation in Imaging

September 13, 2024

Capturing markets: How to commercialize Imaging technology

At the Special Edition Virtual Pub, Angeli Kumari-Illieva (Tampere University), will explore the critical considerations for launching a deep tech startup, based on personal experience, on a presentation entitled, “Capturing Markets: How to commercialise Imaging Technology” 

Special Edition Virtual Pub: Innovation in Imaging

September 13, 2024

Deciding on commercialisation strategy: a business perspective

At this event, Sahar Nassirpour (MR Shim), will explore the the strategic planning and informed decision-making needed to bring a technology to market via case studies and real-life experience. Her talk is entitled “Deciding on commercialisation strategy: a business perspective.”